The ellagitannin metabolite urolithin C attenuated cognitive impairment by inhibiting neuroinflammation via downregulation of MAPK/NF-kB signaling pathways in aging mice
International Immunopharmacology · 2024-12 · 142 · 113151
DOI: 10.1016/j.intimp.2024.113151 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024-12. Verfasst von Peng Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan, Hubei. Electronic address: 2282968908@qq.com. Hauptthemen laut MEDLINE: Coumarins, NF-kappa B, Hydrolyzable Tannins, Aging. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
The current study aimed to evaluate the preventive effects of urolithin C (Uro C), a gut microbial metabolite of ellagitannins on D-galactose (D-gal)-induced brain damage during the aging process and to elucidate the underlying mechanisms. In our study, the protective effect of Uro C on D-gal-induced BV2 microglia cell-mediated neuroinflammation damage in primary cortical neurons in vitro was confirmed. The results in an aging model in vivo induced by D-gal demonstrated that Uro C prevented D-gal-induced memory impairment, long-term potentiation (LTP) damage, and synaptic dysfunction through behavioral, electrophysiological, and histological examinations. Additionally, amyloidogenesis was observed in the central nervous system. The findings indicated that Uro C exhibited a preventive effect on the D-gal-induced elevation of β-amyloid (1-42 specific) (Aβ1-42) accumulation, APP levels, ABCE1 levels, and the equilibrium of the cholinergic system in the aging mouse brain. Moreover, Uro C demonstrated downregulation of D-gal-induced glial overactivation through inhibition of the MAPK/NF-kB pathway. This resulted in the regulation of inflammatory mediators and cytokines, including iNOS, IL-6, IL-1β, and TNF-ɑ, in the mouse brain and BV2 microglial cells. Taken together, our results suggested that Uro C treatment could effectively mitigate the D-gal-induced memory impairment and amyloidogenesis, and the underlying mechanism might be tightly related to the improvement of neuroinflammation by suppressing the MAPK/NF-kB pathway, indicating Uro C might be an alternative and promising agent for the treatment of aging and age-associated brain diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan, Hubei. Electronic address: 2282968908@qq.com.
- Department of Pharmacy, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi.
- Department of Endocrinology, Renmin Hospital of Wuhan University, Wuhan, PR China.
- Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, PR China.
- School of Pharmacy, Hubei University of Traditional Chinese Medicine, Wuhan, PR China.
- Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan, Hubei.
Zitieren
APA
Chen, P., Wu, L., Lei, J., Chen, F., Feng, L., Liu, G., & Zhou, B. (2024). The ellagitannin metabolite urolithin C attenuated cognitive impairment by inhibiting neuroinflammation via downregulation of MAPK/NF-kB signaling pathways in aging mice. International Immunopharmacology, 142, 113151. https://doi.org/10.1016/j.intimp.2024.113151
Vancouver
Chen P, Wu L, Lei J, Chen F, Feng L, Liu G, et al. The ellagitannin metabolite urolithin C attenuated cognitive impairment by inhibiting neuroinflammation via downregulation of MAPK/NF-kB signaling pathways in aging mice. International Immunopharmacology. 2024;142:113151. doi:10.1016/j.intimp.2024.113151
BibTeX
@article{Chen2024,
author = {Chen, Peng and Wu, Lining and Lei, Jiexin and Chen, Fuchao and Feng, Lihua and Liu, Gang and Zhou, Benhong},
title = {The ellagitannin metabolite urolithin C attenuated cognitive impairment by inhibiting neuroinflammation via downregulation of MAPK/NF-kB signaling pathways in aging mice},
journal = {International Immunopharmacology},
year = {2024},
volume = {142},
pages = {113151},
doi = {10.1016/j.intimp.2024.113151}
}
EUVIMED